Use of mouse models to study plasminogen activator inhibitor-1

Methods in Enzymology

Volumn 499, Issue , 2011, Pages 77-104

  Declerck, Paul J ^a   Gils, Ann ^a   De Taeye, Bart ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Animal models; Cancer; Cardiovascular disease; PAI 1; Plasminogen activator inhibitor 1

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITOR; VITRONECTIN;

ARTICLE; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CONFORMATIONAL TRANSITION; FIBROSIS; HUMAN; IN VIVO STUDY; NEOPLASM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALIA; MUS;

EID: 79959369390     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386471-0.00005-5     Document Type: Chapter

References (163)

1. M.C. Alessi, F. Peiretti, P. Morange, M. Henry, G. Nalbone, and I. Juhan-Vague Production of plasminogen activator inhibitor 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease Diabetes 46 1997 860 867 (Pubitemid 27188265)
2. K. Almholt, B.S. Nielsen, T.L. Frandsen, N. Brunner, K. Dano, and M. Johnsen Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice Oncogene 22 2003 4389 4397 (Pubitemid 36897969)
3. P.A. Andreasen PAI-1 - a potential therapeutic target in cancer Curr. Drug Targets 8 2007 1030 1041 (Pubitemid 47578151)
4. P.A. Andreasen, A. Riccio, K.G. Welinder, R. Douglas, R. Sartorio, L.S. Nielsen, C. Oppenheimer, F. Blasi, and K. Dano Plasminogen activator inhibitor type-1: Reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing FEBS Lett. 209 1986 213 218 (Pubitemid 17234210)
5. P.A. Andreasen, B. Georg, L.R. Lund, A. Riccio, and S.N. Stacey Plasminogen activator inhibitors: Hormonally regulated serpins Mol. Cell. Endocrinol. 68 1990 1 19 (Pubitemid 20015463)
6. V. Arnman, A. Nilsson, S. Stemme, B. Risberg, and L. Rymo Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins Thromb. Res. 76 1994 487 499
7. A.T. Askari, M.L. Brennan, X. Zhou, J. Drinko, A. Morehead, J.D. Thomas, E.J. Topol, S.L. Hazen, and M.S. Penn Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction J. Exp. Med. 197 2003 615 624 (Pubitemid 36314656)
8. K. Bajou, A. Noel, R.D. Gerard, V. Masson, N. Brunner, C. Holst-Hansen, M. Skobe, N.E. Fusenig, P. Carmeliet, D. Collen, and J.M. Foidart Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization Nat. Med. 4 1998 923 928 (Pubitemid 28364031)
9. K. Bajou, V. Masson, R.D. Gerard, P.M. Schmitt, V. Albert, M. Praus, L.R. Lund, T.L. Frandsen, N. Brunner, K. Dano, N.E. Fusenig, and U. Weidle The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies J. Cell Biol. 152 2001 777 784 (Pubitemid 34280162)
10. K. Bajou, C. Maillard, M. Jost, R.H. Lijnen, A. Gils, P. Declerck, P. Carmeliet, J.M. Foidart, and A. Noel Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth Oncogene 23 2004 6986 6990 (Pubitemid 39279999)
11. K. Bajou, H. Peng, W.E. Laug, C. Maillard, A. Noel, J.M. Foidart, J.A. Martial, and Y.A. DeClerck Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis Cancer Cell 14 2008 324 334
12. M. Becker, T. Szarvas, M. Wittschier, F. Vom Dorp, M. Totsch, K.W. Schmid, H. Rubben, and S. Ergun Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer Cancer 116 19 2010 4502 4512
13. A.P. Bijnens, I. Knockaert, E. Cousin, E.K. Kruithof, and P.J. Declerck Expression and characterization of recombinant porcine plasminogen activator inhibitor-1 Thromb. Haemost. 77 1997 350 356 (Pubitemid 27084929)
14. B.R. Binder, and J. Mihaly The plasminogen activator inhibitor "paradox" in cancer Immunol. Lett. 118 2008 116 124
15. B.R. Binder, J. Mihaly, and G.W. Prager uPAR-uPA-PAI-1 interactions and signaling: A vascular biologist's view Thromb. Haemost. 97 2007 336 342 (Pubitemid 46437793)
16. N.A. Booth, A.J. Simpson, A. Croll, B. Bennett, and I.R. MacGregor Plasminogen activator inhibitor (PAI-1) in plasma and platelets Br. J. Haematol. 70 1988 327 333 (Pubitemid 18265252)
17. S. Brodsky, J. Chen, A. Lee, K. Akassoglou, J. Norman, and M.S. Goligorsky Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis Am. J. Physiol. Heart Circ. Physiol. 281 2001 H1784 H1792
18. F. Bruyere, L. Melen-Lamalle, S. Blacher, B. Detry, A. Masset, J. Lecomte, V. Lambert, C. Maillard, G. Hoyer-Hansen, L.R. Lund, J.M. Foidart, and A. Noel Does plasminogen activator inhibitor-1 drive lymphangiogenesis? PLoS ONE 5 2010 e9653
19. P. Carmeliet, L. Kieckens, L. Schoonjans, B. Ream, A. van Nuffelen, G. Prendergast, M. Cole, R. Bronson, D. Collen, and R.C. Mulligan Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization J. Clin. Invest. 92 1993 2746 2755 (Pubitemid 24006540)
20. P. Carmeliet, J.M. Stassen, L. Schoonjans, B. Ream, J.J. van den Oord, M. De Mol, R.C. Mulligan, and D. Collen Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis J. Clin. Invest. 92 1993 2756 2760 (Pubitemid 24006541)
21. P. Carmeliet, L. Moons, R. Lijnen, S. Janssens, F. Lupu, D. Collen, and R.D. Gerard Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: A gene targeting and gene transfer study in mice Circulation 96 1997 3180 3191 (Pubitemid 27500124)
22. J. Chmielewska, M. Ranby, and B. Wiman Evidence for a rapid inhibitor to tissue plasminogen activator in plasma Thromb. Res. 31 1983 427 436 (Pubitemid 14227764)
23. A.C.A. Cleuren, B. van Hoef, M.F. Hoylaerts, B.J.M. van Vlijmen, and H.R. Lijnen Short-term ethinylestradiol treatment suppresses inferior caval vein thrombosis in obese mice Thromb. Haemost. 102 2009 993 1000
24. B.C. Cooley, L. Szema, C.Y. Chen, J.P. Schwab, and G. Schmeling A murine model of deep vein thrombosisCharacterization and validation in transgenic mice Thromb. Haemost. 94 2005 498 503 (Pubitemid 41300842)
25. A. Curino, D.J. Mitola, H. Aaronson, G.A. McMahon, K. Raja, A.D. Keegan, D.A. Lawrence, and T.H. Bugge Plasminogen promotes sarcoma growth and suppresses the accumulation of tumor-infiltrating macrophages Oncogene 21 2002 8830 8842 (Pubitemid 36132403)
26. R.-P. Czekay, and D.J. Loskutoff Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment Exp. Biol. Med. 229 2004 1090 1096 (Pubitemid 39602250)
27. V. de Waard, E.K. Arkenbout, P. Carmeliet, V. Lindner, and H. Pannekoek Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model Arterioscler. Thromb. Vasc. Biol. 22 2002 1978 1983 (Pubitemid 36025202)
28. S. Debrock, and P.J. Declerck Neutralization of plasminogen activator inhibitor-1 inhibitory properties: Identification of two different mechanisms Biochim. Biophys. Acta Protein Struct. Mol. Enzymol. 1337 1997 257 266 (Pubitemid 27073496)
29. P.J. Declerck, M.C. Alessi, M. Verstreken, E.K. Kruithof, I. Juhan-Vague, and D. Collen Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay Blood 71 1988 220 225 (Pubitemid 18050415)
30. P.J. Declerck, M. De Mol, M.C. Alessi, S. Baudner, E.P. Paques, K.T. Preissner, G. Muller-Berghaus, and D. Collen Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin) J. Biol. Chem. 263 1988 15454 15461
31. P.J. Declerck, I. Juhan-Vague, J. Felez, and B. Wiman Pathophysiology of fibrinolysis J. Intern. Med. 236 1994 425 432 (Pubitemid 24323204)
32. P.J. Declerck, M. Verstreken, and D. Collen Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice Thromb. Haemost. 74 1995 1305 1309
33. L. Devy, S. Blacher, C. Grignet-Debrus, K. Bajou, V. Masson, R.D. Gerard, A. Gils, G. Carmeliet, P. Carmeliet, P.J. Declerck, A. Noel, and J.M. Foidart The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent FASEB J. 16 2002 147 154 (Pubitemid 34113008)
34. M. Dewilde, B. Van De Craen, G. Compernolle, J.B. Madsen, S. Strelkov, A. Gils, and P.J. Declerck Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differences J. Struct. Biol. 171 2010 95 101
35. J.A. Diaz, A.E. Hawley, C.M. Alvarado, A.M. Berguer, N.K. Baker, S.K. Wrobleski, T.W. Wakefield, B.R. Lucchesi, and D.D. Myers Thrombogenesis with continuous blood flow in the inferior vena cava A novel mouse model Thromb. Haemost. 104 2010 366 375
36. J. Dieval, G. Nguyen, S. Gross, J. Delobel, and E.K. Kruithof A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1 Blood 77 1991 528 532
37. M.J. Duffy, P.M. McGowan, and W.M. Gallagher Cancer invasion and metastasis: Changing views J. Pathol. 214 2008 283 293 (Pubitemid 351212383)
38. M.K. Durand, J.S. Bodker, A. Christensen, D.M. Dupont, M. Hansen, J.K. Jensen, S. Kjelgaard, L. Mathiasen, K.E. Pedersen, S. Skeldal, T. Wind, and P.A. Andreasen Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis Thromb. Haemost. 91 2004 438 449 (Pubitemid 38396865)
39. D.T. Eitzman, J.C. Krauss, T. Shen, J. Cui, and Ginsburg Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma Blood 87 1996 4718 4722 (Pubitemid 26162371)
40. D.T. Eitzman, R.D. McCoy, X. Zheng, W.P. Fay, T. Shen, D. Ginsburg, and R.H. Simon Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene J. Clin. Invest. 97 1996 232 237 (Pubitemid 26021713)
41. D.T. Eitzman, R.J. Westrick, E.G. Nabel, and D. Ginsburg Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice Blood 95 2000 577 580 (Pubitemid 30041672)
42. D.T. Eitzman, R.J. Westrick, Z. Xu, J. Tyson, and D. Ginsburg Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery Blood 96 2000 4212 4215
43. M. Eren, C.A. Painter, J.B. Atkinson, P.J. Declerck, and D.E. Vaughan Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1 Circulation 106 2002 491 496 (Pubitemid 34803696)
44. M. Eren, L.A. Gleaves, J.B. Atkinson, L.E. King, P.J. Declerck, and D.E. Vaughan Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice J. Thromb. Haemost. 5 2007 1500 1508 (Pubitemid 46965381)
45. L.A. Erickson, M.H. Ginsberg, and D.J. Loskutoff Detection and partial characterization of an inhibitor of plasminogen activator in human platelets J. Clin. Invest. 74 1984 1465 1472 (Pubitemid 15200241)
46. L.A. Erickson, G.J. Fici, J.E. Lund, T.P. Boyle, H.G. Polites, and K.R. Marotti Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene Nature 346 1990 74 76
47. A.T. Fahim, H. Wang, J. Feng, and D. Ginsburg Transgenic overexpression of a stable plasminogen activator inhibitor-1 variant Thromb. Res. 123 2009 785 792
48. P.M. Farrehi, C.K. Ozaki, P. Carmeliet, and W.P. Fay Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice Circulation 97 1998 1002 1008 (Pubitemid 28125473)
49. W.P. Fay, A.D. Shapiro, J.L. Shih, R.R. Schleef, and D. Ginsburg Brief report: Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation N. Engl. J. Med. 327 1992 1729 1733
50. W.P. Fay, A.C. Parker, L.R. Condrey, and A.D. Shapiro Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene Blood 90 1997 204 208 (Pubitemid 27276563)
51. W.P. Fay, A.C. Parker, M.N. Ansari, X. Zheng, and D. Ginsburg Vitronectin inhibits the thrombotic response to arterial injury in mice Blood 93 1999 1825 1830 (Pubitemid 29128482)
52. W.P. Fay, N. Garg, and M. Sunkar Vascular functions of the plasminogen activation system Arterioscler. Thromb. Vasc. Biol. 27 2007 1231 1237 (Pubitemid 46809410)
53. A.R. Folsom, N. Aleksic, E. Park, V. Salomaa, H. Juneja, and K.K. Wu Prospective study of fibrinolytic factors and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study Arterioscler. Thromb. Vasc. Biol. 21 2001 611 617 (Pubitemid 32323396)
54. C.W. Francis Plasminogen activator inhibitor-1 levels and polymorphisms Arch. Pathol. Lab. Med. 126 2002 1401 1404
55. S. Gao, B.S. Nielsen, A. Krogdahl, J.A. Sorensen, J. Tagesen, S. Dabelsteen, E. Dabelsteen, and P.A. Andreasen Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa Genes Chromosomes Cancer 49 2010 526 538
56. A. Gils, K.E. Pedersen, P. Skottrup, A. Christensen, D. Naessens, J. Deinum, J.J. Enghild, P.J. Declerck, and P.A. Andreasen Biochemical importance of glycosylation of plasminogen activator inhibitor-1 Thromb. Haemost. 90 2003 206 217 (Pubitemid 37006281)
57. A. Gils, L.M. Meissenheimer, G. Compernolle, and P.J. Declerck Species-dependent molecular drug targets in plasminogen activator inhibitor-1 (PAI-1) Thromb. Haemost. 102 2009 609 610
58. D. Ginsburg, R. Zeheb, A.Y. Yang, U.M. Rafferty, P.A. Andreasen, L. Nielsen, K. Dano, R.V. Lebo, and T.D. Gelehrter cDNA cloning of human plasminogen activator-inhibitor from endothelial cells J. Clin. Invest. 78 1986 1673 1680 (Pubitemid 17219532)
59. M.W. Gramling, and F.C. Church Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment Thromb. Res. 125 2010 377 381
60. L.S. Gutierrez, A. Schulman, T. Brito-Robinson, F. Noria, V.A. Ploplis, and F.J. Castellino Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1 Cancer Res. 60 2000 5839 5847
61. A. Hamsten, B. Wiman, U. de Faire, and M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N. Engl. J. Med. 313 1985 1557 1563 (Pubitemid 16177394)
62. K.R. Heberlein, A.C. Straub, A.K. Best, M.A. Greyson, R.C. Looft-Wilson, P.R. Sharma, A. Meher, N. Leitinger, and B.E. Isakson Plasminogen activator inhibitor-1 regulates myoendothelial junction formation Circ. Res. 106 2010 1092 1102
63. C.M. Hekman, and D.J. Loskutoff Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants J. Biol. Chem. 260 1985 11581 11587 (Pubitemid 16252157)
64. K.J. Hofmann, E.J. Mayer, L.D. Schultz, S.H. Socher, and C.F. Reilly Purification and characterization of recombinant rabbit plasminogen activator inhibitor-1 expressed in Saccharomyces cerevisae Fibrinolysis 6 1992 263 272
65. J.P. Irigoyen, P. Munoz-Canoves, L. Montero, M. Koziczak, and Y. Nagamine The plasminogen activator system: Biology and regulation Cell. Mol. Life Sci. 56 1999 104 132 (Pubitemid 29471930)
66. Y. Izuhara, S. Takahashi, M. Nangaku, S.Y. Takizawa, H. Ishida, K. Kurokawa, C.V. de Strihou, N. Hirayama, and T. Miyata Inhibition of plasminogen activator inhibitor-1 - Its mechanism and effectiveness on coagulation and fibrosis Arterioscler. Thromb. Vasc. Biol. 28 2008 672 677 (Pubitemid 351651332)
67. F. Janicke, M. Schmitt, L. Pache, K. Ulm, N. Harbeck, H. Hofler, and H. Graeff Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer Breast Cancer Res. Treat. 24 1993 195 208 (Pubitemid 23062819)
68. I. Juhan-Vague, M.C. Alessi, and P.J. Declerck Pathophysiology of fibrinolysis Baillires Clin. Haematol. 8 1995 329 343
69. I. Juhan-Vague, S.D. Pyke, M.C. Alessi, J. Jespersen, F. Haverkate, and S.G. Thompson Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities Circulation 94 1996 2057 2063 (Pubitemid 26360493)
70. K. Kaikita, A.B. Fogo, L. Ma, J.A. Schoenhard, N.J. Brown, and D.E. Vaughan Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition Circulation 104 2001 839 844 (Pubitemid 32762685)
71. K. Kaikita, J.A. Schoenhard, C.A. Painter, R.T. Ripley, N.J. Brown, A.B. Fogo, and D.E. Vaughan Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition J. Mol. Cell. Cardiol. 34 2002 617 627 (Pubitemid 35222847)
72. T. Kawasaki, M. Dewerchin, H.R. Lijnen, J. Vermylen, and M.F. Hoylaerts Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice Blood 96 2000 153 160 (Pubitemid 30456465)
73. T. Kawasaki, M. Dewerchin, H.R. Lijnen, I. Vreys, J. Vermylen, and M.F. Hoylaerts Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development Circ. Res. 88 2001 159 166 (Pubitemid 32147303)
74. S. Kikuchi, K. Umemura, K. Kondo, A.R. Saniabadi, and M. Nakashima Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening Arterioscler. Thromb. Vasc. Biol. 18 1998 1069 1078 (Pubitemid 28323591)
75. A. Knoop, P.A. Andreasen, J.A. Andersen, S. Hansen, A.V. Laenkholm, A.C. Simonsen, J. Andersen, J. Overgaard, and C. Rose Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer Br. J. Cancer 77 1998 932 940 (Pubitemid 28101782)
76. G. Konecny, M. Untch, A. Pihan, R. Kimmig, M. Gropp, P. Stieber, H. Hepp, D. Slamon, and M. Pegram Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer Clin. Cancer Res. 7 2001 1743 1749 (Pubitemid 32708644)
77. S. Konstantinides, K. Schafer, T. Thinnes, and D.J. Loskutoff Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice Circulation 103 2001 576 583 (Pubitemid 32116244)
78. R.F. Kornelisse, J.A. Hazelzet, H.F. Savelkoul, W.C. Hop, M.H. Suur, A.N. Borsboom, I.M. Risseeuw-Appel, E. van der Voort, and R. de Groot The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock J. Infect. Dis. 173 1996 1148 1156 (Pubitemid 26251457)
79. S. Koschnick, S. Konstantinides, K. Schafer, K. Crain, and D.J. Loskutoff Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin J. Thromb. Haemost. 3 2005 2290 2295 (Pubitemid 41727209)
80. E.K. Kruithof, G. Nicolosa, and F. Bachmann Plasminogen activator inhibitor 1: Development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation Blood 70 1987 1645 1653 (Pubitemid 18026182)
81. W. Kuhn, B. Schmalfeldt, U. Reuning, L. Pache, U. Berger, K. Ulm, N. Harbeck, K. Spathe, P. Dettmar, H. Hofler, F. Janicke, and M. Schmitt Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc Br. J. Cancer 79 1999 1746 1751 (Pubitemid 29132299)
82. K.D. Kurz, B.W. Main, and G.E. Sandusky Rat model of arterial thrombosis induced by ferric chloride Thromb. Res. 60 1990 269 280
83. H.C. Kwaan, J. Wang, K. Svoboda, and P.J. Declerck Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis Br. J. Cancer 82 2000 1702 1708 (Pubitemid 30229582)
84. V. Lambert, C. Munaut, P. Carmeliet, R.D. Gerard, P.J. Declerck, A. Gils, C. Claes, J.M. Foidart, A. Noel, and J.M. Rakic Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: Implications for clinical trials Invest. Ophthalmol. Vis. Sci. 44 2003 2791 2797 (Pubitemid 36618445)
85. D. Lawrence, L. Strandberg, T. Grundstrom, and T. Ny Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells Eur. J. Biochem. 186 1989 523 533 (Pubitemid 20030102)
86. M.H. Lee, E. Vosburgh, K. Anderson, and J. McDonagh Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding Blood 81 1993 2357 2362 (Pubitemid 23127070)
87. C.E. Leik, E.J. Su, P. Nambi, D.L. Crandall, and D.A. Lawrence Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis J. Thromb. Haemost. 4 2006 2710 2715 (Pubitemid 44741569)
88. Li, S. H., and Lawrence, D. A. Development of inhibitors of plasminogen activator inhibitors-1. Methods in Enzymol. Manuscript submitted for publication
89. H. Lijnen Pleiotropic functions of plasminogen activator inhibitor-1 J. Thromb. Haemost. 3 2005 35 45 (Pubitemid 41647113)
90. H.R. Lijnen, B. van Hoef, V. Beelen, and D. Collen Characterization of the murine plasma fibrinolytic system Eur. J. Biochem. 224 1994 863 871 (Pubitemid 24288847)
91. H.R. Lijnen, E. Maquoi, P. Morange, G. Voros, B. Van Hoef, F. Kopp, D. Collen, I. Juhan-Vague, and M.C. Alessi Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1 Arterioscler. Thromb. Vasc. Biol. 23 2003 78 84 (Pubitemid 36091629)
92. H.R. Lijnen, B. Van Hoef, K. Umans, and D. Collen Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1) J. Thromb. Haemost. 2 2004 16 22 (Pubitemid 40185614)
93. D.J. Loskutoff, J.A. van Mourik, L.A. Erickson, and D. Lawrence Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells Proc. Natl. Acad. Sci. USA 80 1983 2956 2960 (Pubitemid 13104156)
94. D.J. Loskutoff, M. Sawdey, and J. Mimuro Type 1 plasminogen activator inhibitor Prog. Hemost. Thromb. 9 1989 87 115
95. F. Lupu, G.E. Bergonzelli, D.A. Heim, E. Cousin, C.Y. Genton, F. Bachmann, and E.K. Kruithof Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries Arterioscler. Thromb. 13 1993 1090 1100 (Pubitemid 23195812)
96. A. Luttun, F. Lupu, E. Storkebaum, M.F. Hoylaerts, L. Moons, J. Crawley, F. Bono, A.R. Poole, P. Tipping, J.M. Herbert, D. Collen, and P. Carmeliet Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 22 2002 499 505 (Pubitemid 34218761)
97. C. Maillard, M. Jost, M.U. Romer, N. Brunner, X. Houard, A. Lejeune, C. Munaut, K. Bajou, L. Melen, K. Dano, P. Carmeliet, and N.E. Fusenig Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner Neoplasia 7 2005 57 66 (Pubitemid 40209471)
98. C.M. Maillard, C. Bouquet, M.M. Petitjean, M. Mestdagt, E. Frau, M. Jost, A.M. Masset, P.H. Opolon, F. Beermann, M.M. Abitbol, J.M. Foidart, and M.J. Perricaudet Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors Carcinogenesis 29 2008 2236 2242
99. A. Masset, C. Maillard, N. Sounni, N. Jacobs, F. Bruyere, P. Delvenne, M. Tacke, T. Reinheckel, J.M. Foidart, L. Coussens, and A. Noel Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor Int. J. Cancer 128 2011 283 293
100. H. Matsuno, T. Uematsu, S. Nagashima, and M. Nakashima Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model J. Pharmacol. Methods 25 1991 303 317
101. H. Matsuno, O. Kozawa, M. Niwa, S. Ueshima, O. Matsuo, D. Collen, and T. Uematsu Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury Thromb. Haemost. 81 1999 601 604 (Pubitemid 29178949)
102. O. Matsuo, H.R. Lijnen, S. Ueshima, S. Kojima, and S.S. Smyth A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations J. Thromb. Haemost. 5 2007 680 689 (Pubitemid 46563564)
103. A.P. McDonald, T.R. Meier, A.E. Hawley, J.N. Thibert, D.M. Farris, S.K. Wrobleski, P.K. Henke, T.W. Wakefield, and D.D. Myers Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis Thromb. Res. 125 2010 72 78
104. B. McMahon, and H.C. Kwaan The plasminogen activator system and cancer Pathophysiol. Haemost. Thromb. 36 2008 184 194
105. G.A. McMahon, E. Petitclerc, S. Stefansson, E. Smith, M.K. Wong, R.J. Westrick, D. Ginsburg, P.C. Brooks, and D.A. Lawrence Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis J. Biol. Chem. 276 2001 33964 33968
106. T.W. Meade, V. Ruddock, Y. Stirling, R. Chakrabarti, and G.J. Miller Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 342 1993 1076 1079 (Pubitemid 23338739)
107. R.L. Medcalf Fibrinolysis, inflammation, and regulation of the plasminogen activating system J. Thromb. Haemost. 5 Suppl. 1 2007 132 142 (Pubitemid 46958826)
108. L.M. Meissenheimer, K. Verbeke, P.J. Declerck, and A. Gils Quantitation of Vervet monkey (Chlorocebus aethiops) plasminogen activator inhibitor-1 in plasma and platelets Thromb. Haemost. 95 2006 902 903
109. R.M. Mesters, N. Florke, H. Ostermann, and J. Kienast Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis Thromb. Haemost. 75 1996 902 907 (Pubitemid 26355345)
110. J. Mimuro, M. Sawdey, M. Hattori, and D. Loskutoff cDNA for bovine type 1 plasminogen activator inhibitor (PAI-1) Nucleic Acid Res. 17 1989 8872 (Pubitemid 19273895)
111. H. Moriwaki, A. Stempien-Otero, M. Kremen, A.E. Cozen, and D.A. Dichek Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice Circ. Res. 95 2004 637 644 (Pubitemid 39274379)
112. D. Myers, D. Farris, A. Hawley, S. Wrobleski, A. Chapman, L. Stoolman, R. Knibbs, R. Strieter, and T. Wakefield Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis J. Surg. Res. 108 2002 212 221 (Pubitemid 36062701)
113. N. Nagai, M. De Mol, H.R. Lijnen, P. Carmeliet, and D. Collen Role of plasminogen system components in focal cerebral ischemic infarction: A gene targeting and gene transfer study in mice Circulation 99 1999 2440 2444 (Pubitemid 29218241)
114. N. Nagai, Y. Suzuki, B. Van Hoef, H.R. Lijnen, and D. Collen Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice J. Thromb. Haemost. 3 2005 1379 1384 (Pubitemid 41725193)
115. N. Nagai, B. Van Hoef, and H.R. Lijnen Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice J. Thromb. Haemost. 5 2007 1726 1731 (Pubitemid 47091417)
116. Y. Nakashima, A.S. Plump, E.W. Raines, J.L. Breslow, and R. Ross ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree Arterioscler. Thromb. 14 1994 133 140
117. M. Narayanaswamy, K.C. Wright, and K. Kandarpa Animal models for atherosclerosis, restenosis, and endovascular graft research J. Vasc. Interv. Radiol. 11 2000 5 17 (Pubitemid 30067203)
118. H. Nekarda, J.R. Siewert, M. Schmitt, and K. Ulm Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer Lancet 343 1994 117 (Pubitemid 24019365)
119. I.M. Nilsson, H. Ljungner, and L. Tengborn Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor Br. Med. J. Clin. Res. Ed. 290 1985 1453 1456 (Pubitemid 15076477)
120. T.K. Nordt, H. Sawa, S. Fujii, C. Bode, and B.E. Sobel Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo J. Mol. Cell. Cardiol. 30 1998 1535 1543 (Pubitemid 28418644)
121. Y. Numaguchi, M. Ishii, R. Kubota, Y. Morita, K. Yamamoto, T. Matsushita, K. Okumura, and T. Murohara Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis Arterioscler. Thromb. Vasc. Biol. 29 2009 2102 2108
122. T. Ny, M. Sawdey, D. Lawrence, J.L. Millan, and D.J. Loskutoff Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor Proc. Natl. Acad. Sci. USA 83 1986 6776 6780 (Pubitemid 16002316)
123. G. Otsuka, R. Agah, A.D. Frutkin, T.N. Wight, and D.A. Dichek Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways Arterioscler. Thromb. Vasc. Biol. 26 2006 737 743 (Pubitemid 43732145)
124. D.A. Owensby, P.A. Morton, T.C. Wun, and A.L. Schwartz Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin J. Biol. Chem. 266 1991 4334 4340 (Pubitemid 21909361)
125. H. Pannekoek, H. Veerman, H. Lambers, P. Diergaarde, C.L. Verweij, A.J. van Zonneveld, and J.A. van Mourik Endothelial plasminogen activator inhibitor (PAI): A new member of the Serpin gene family EMBO J. 5 1986 2539 2544
126. L. Peng, N. Bhatia, A.C. Parker, Y. Zhu, and W.P. Fay Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries Arterioscler. Thromb. Vasc. Biol. 22 2002 934 939 (Pubitemid 34655220)
127. S.S. Pierangeli, and E.N. Harris Antiphospholipid antibodies in an in vivo thrombosis model in mice Lupus 3 1994 247 251 (Pubitemid 24277035)
128. S.S. Pierangeli, X.W. Liu, J.H. Barker, G. Anderson, and E.N. Harris Induction of thrombosis in a mouse model by IgG. IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome Thromb. Haemost. 74 1995 1361 1367
129. V.A. Ploplis, I. Cornelissen, M.J. Sandoval-Cooper, L. Weeks, F.A. Noria, and F.J. Castellino Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1 Am. J. Pathol. 158 2001 107 117 (Pubitemid 32096476)
130. G.C. Prendergast, L.E. Diamond, D. Dahl, and M.D. Cole The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1 Mol. Cell. Biol. 10 1990 1265 1269
131. M.H. Prins, and J. Hirsh A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism Arch. Intern. Med. 151 1991 1721 1731
132. D.C. Rijken, and H.R. Lijnen New insights into the molecular mechanisms of the fibrinolytic system J. Thromb. Haemost. 7 2009 4 13
133. L.A. Robbie, N.A. Booth, A.J. Brown, and B. Bennett Inhibitors of fibrinolysis are elevated in atherosclerotic plaque Arterioscler. Thromb. Vasc. Biol. 16 1996 539 545 (Pubitemid 26107725)
134. R.M. Sandford, M.J. Bown, N.J. London, and R.D. Sayers The genetic basis of abdominal aortic aneurysms: A review Eur. J. Vasc. Endovasc. Surg. 33 2007 381 390 (Pubitemid 46336592)
135. K. Schafer, K. Muller, A. Hecke, E. Mounier, J. Goebel, D.J. Loskutoff, and S. Konstantinides Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1 Arterioscler. Thromb. Vasc. Biol. 23 2003 2097 2103 (Pubitemid 37433206)
136. K. Schafer, M.R. Schroeter, C. Dellas, M. Puls, M. Nitsche, E. Weiss, G. Hasenfuss, and S.V. Konstantinides Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice Arterioscler. Thromb. Vasc. Biol. 26 2006 1254 1259 (Pubitemid 44305367)
137. D.J. Schneider, M. Hayes, M. Wadsworth, H. Taatjes, M. Rincon, D.J. Taatjes, and B.E. Sobel Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1) J. Histochem. Cytochem. 52 2004 1091 1099 (Pubitemid 38982198)
138. J. Schneiderman, M.S. Sawdey, M.R. Keeton, G.M. Bordin, E.F. Bernstein, R.B. Dilley, and D.J. Loskutoff Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries Proc. Natl. Acad. Sci. USA 89 1992 6998 7002
139. S. Schulman, and B. Wiman The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group Thromb. Haemost. 75 1996 607 611 (Pubitemid 26141443)
140. D. Seiffert, J. Mimuro, R.R. Schleef, and D.J. Loskutoff Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin Cell Differ. Dev. 32 1990 287 292
141. T. Senoo, N. Hattori, T. Tanimoto, M. Furonaka, N. Ishikawa, K. Fujitaka, Y. Haruta, H. Murai, A. Yokoyama, and N. Kohno Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis Thorax 65 2010 334 340
142. H.J. Siemens, S. Brueckner, S. Hagelberg, T. Wagner, and P. Schmucker Course of molecular hemostatic markers during and after different surgical procedures J. Clin. Anesth. 11 1999 622 629 (Pubitemid 30064441)
143. A.J. Simpson, N.A. Booth, N.R. Moore, and B. Bennett Distribution of plasminogen activator inhibitor (PAI-1) in tissues J. Clin. Pathol. 44 1991 139 143
144. I. Singh, A. Smith, B. Vanzieleghem, D. Collen, K. Burnand, J.M. St-Remy, and M. Jacquemin Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model Blood 99 2002 3235 3240 (Pubitemid 34525303)
145. H. Sjoland, D.T. Eitzman, D. Gordon, R. Westrick, E.G. Nabel, and D. Ginsburg Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1 Arterioscler. Thromb. Vasc. Biol. 20 2000 846 852 (Pubitemid 30151702)
146. L.H. Smith, J.D. Dixon, J.R. Stringham, M. Eren, H. Elokdah, D.L. Crandall, K. Washington, and D.E. Vaughan Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis Blood 107 2006 132 134 (Pubitemid 43053534)
147. G.A. Soff, J. Sanderowitz, S. Gately, E. Verrusio, I. Weiss, S. Brem, and H.C. Kwaan Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model J. Clin. Invest. 96 1995 2593 2600
148. S. Stefansson, E. Petitclerc, M.K. Wong, G.A. McMahon, P.C. Brooks, and D.A. Lawrence Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1 J. Biol. Chem. 276 2001 8135 8141
149. K. Takeshita, M. Hayashi, S. Iino, T. Kondo, Y. Inden, M. Iwase, T. Kojima, M. Hirai, M. Ito, D.J. Loskutoff, H. Saito, and T. Murohara Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction Am. J. Pathol. 164 2004 449 456 (Pubitemid 38364661)
150. A.M. Thogersen, J.H. Jansson, K. Boman, T.K. Nilsson, L. Weinehall, F. Huhtasaari, and G. Hallmans High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor Circulation 98 1998 2241 2247 (Pubitemid 28533841)
151. Van de Craen, B., Scroyen, I., Abdelnabi, R., Brouwers, E., Lijnen, H. R., Declerck, P. J., and Gils, A. Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivo. Thromb. Res. Mar 8. [Epub ahead of print]
152. D.E. Vaughan PAI-1 and atherothrombosis J. Thromb. Haemost. 3 2005 1879 1883 (Pubitemid 41716575)
153. D.E. Vaughan, P.J. Declerck, E. Van Houtte, M. De Mol, and D. Collen Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo Circ. Res. 67 1990 1281 1286 (Pubitemid 20368025)
154. A.D. Weisberg, F. Albornoz, J.P. Griffin, D.L. Crandall, H. Elokdah, A.B. Fogo, D.E. Vaughan, and N.J. Brown Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling Arterioscler. Thromb. Vasc. Biol. 25 2005 365 371 (Pubitemid 40189159)
155. R.J. Westrick, M.E. Winn, and D.T. Eitzman Murine models of vascular thrombosis (Eitzman series) Arterioscler. Thromb. Vasc. Biol. 27 2007 2079 2093 (Pubitemid 350287234)
156. H.C. Whinna Overview of murine thrombosis models Thromb. Res. 122 2008 S64 S69
157. B. Wiman, B. Ljungberg, J. Chmielewska, G. Urden, M. Blomback, and H. Johnsson The role of the fibrinolytic system in deep vein thrombosis J. Lab. Clin. Med. 105 1985 265 270 (Pubitemid 15036948)
158. Z. Xu, F.J. Castellino, and V.A. Ploplis Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture Blood 115 2010 2038 2047
159. Y. Xue, P. Bjorquist, T. Inghardt, M. Linschoten, D. Musil, L. Sjolin, and J. Deinum Interfering with the inhibitory mechanism of serpins: Crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide Structure 6 1998 627 636 (Pubitemid 28258115)
160. A.K. Zaman, C.J. French, D.J. Schneider, and B.E. Sobel A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart Exp. Biol. Med. (Maywood) 234 2009 246 254
161. R. Zeheb, and T.D. Gelehrter Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1 Gene 73 1988 459 468 (Pubitemid 19043277)
162. Y. Zhu, P. Carmeliet, and W.P. Fay Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance Circulation 99 1999 3050 3055 (Pubitemid 29270436)
163. Y. Zhu, P.M. Farrehi, and W.P. Fay Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice Circulation 103 2001 3105 3110 (Pubitemid 32590831)